Hamilton Thorne
→
Astorg
Acquisition · Cash · announced Jul 22, 2024
Announced
Jul 22, 2024
Closed
Dec 2, 2024
Economics
Cash()
Pre-deal · pre-deal mark: 2024, year precision · Astorg press release — Hamilton Thorne acquisition, 2024
C$10.50/share take-private; ~$282M equity value (Weil/Astorg announcement)
Target
Hamilton Thorne
Fertility · Fertility science
HQ Beverly, MA · Founded 1988
Precision laser devices, advanced imaging systems, consumables and software for assisted reproductive technology (ART) and IVF labs — products used in 115+ countries
- Business Wire — Astorg press release (Dec 2, 2024)
- Mergr M&A summary ($388M total)
- Weil Gotshal advisory announcement ($282M)
Acquirer
Astorg
Fertility
HQ Luxembourg
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Combined with Cook Medical RH to create global ART/IVF leader — precision laser instruments and advanced imaging serving 115+ countries
Evidence ladder
Secondary (press / IR)
Business Wire — Astorg press release (Dec 2, 2024)
Tertiary (trade / analyst)
Weil Gotshal advisory announcement (Jul 24, 2024)
Limitations
- Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
- C$10.50/share take-private; ~$282M equity value (Weil/Astorg announcement)
- Pre-deal valuation sourced from: Astorg press release — Hamilton Thorne acquisition, 2024. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Fertility
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.
| Why included | ||||
|---|---|---|---|---|
| Eugin Group (North American operations) | KKR (via IVI-RMA) | Nov 1, 2023 | same evidence class | |
| Indira IVF | BPEA EQT | Jul 28, 2023 | same evidence class | |
| Modern Fertility | Ro | May 19, 2021 | value band |
Same-sector adjacency — not valuation peers
These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.
| Vs this deal | ||||
|---|---|---|---|---|
| IVI-RMA Global | KKR | Mar 1, 2022 |
Other verified deals by Astorg
Acquirer program history not already listed as a valuation peer or adjacency row.
No further verified deals
Other verified transactions by Astorg are already listed above, or none are in the dataset.
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Hamilton Thorne (Fertility). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v11 · updated 2026-10-19 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.